Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Journal of Colorado.
Press releases published on May 22, 2025
Acceleware Ltd. Reports First Quarter 2025 Financial and Operating Results
GlobeNewswire
·
May 22, 2025
CALGARY, Alberta, May 22, 2025 (GLOBE NEWSWIRE) -- Acceleware® Ltd. (“Acceleware” or the “Company”) (TSX-V: AXE), an advanced electromagnetic (“EM”) heating company with highly scalable solutions for large industrial applications, today announced its …
ImPact Biotech Announces Late-Breaking Podium Presentation at ASCO 2025 Highlighting ENLIGHTED Study Interim Analysis
GlobeNewswire
·
May 22, 2025
-- Company to present interim update from ENLIGHTED Phase 3 Study in LG UTUC following assessment of 50% of targeted total evaluable patient enrollment -- TEL AVIV, Israel, May 22, 2025 (GLOBE NEWSWIRE) -- ImPact Biotech, a clinical-stage biotechnology …
Linvoseltamab in Combination with Carfilzomib or Bortezomib Shows Promising Initial Results in Earlier Lines of Treatment for Relapsed/Refractory Multiple Myeloma
GlobeNewswire
·
May 22, 2025
First results to be presented in two ASCO oral presentations Data in both combinations demonstrate high response rates TARRYTOWN, N.Y., May 22, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced initial results from two …
Zymeworks Announces Presentations Highlighting Breadth of Oncology Portfolio at Upcoming Medical Conferences
GlobeNewswire
·
May 22, 2025
Partner presentations reinforce ability of proprietary Azymetric™ platform to develop clinically validated therapeutic antibodies Long-term outcomes and survival data for Ziihera® (zanidatamab-hrii), which was developed using Azymetric™, to be presented at …
COOFANDY Marks 10th Anniversary with Dual Silver Awards at Berlin and New York Product Design Competitions
GlobeNewswire
·
May 22, 2025
New York, NY, May 22, 2025 (GLOBE NEWSWIRE) -- As COOFANDY celebrates its 10th anniversary in 2025, the brand has reached an exciting new milestone: The COOFANDY Men’s Short-Sleeve Casual Shirts have earned Silver Awards at both the 2025 Berlin Design …
A new passive income solution for 2025: Efficiently participate in Bitcoin and cryptocurrency mining with PairMiner
GlobeNewswire
·
May 22, 2025
Washington, D.C., USA, May 22, 2025 (GLOBE NEWSWIRE) -- PAIRMiner, an advanced platform offering mining power services. Recently, Bitcoin has made a strong comeback, with its price soaring and reigniting global investors' passion and confidence in …
Best Dogecoin & Bitcoin Mining Site of 2025: FioBit Launches the Most Profitable AI Cloud Miner to Help Crypto Investors Earn Faster
GlobeNewswire
·
May 22, 2025
Sydney, Australia, May 22, 2025 (GLOBE NEWSWIRE) -- As the cryptocurrency market continues to mature in 2025, cloud mining has emerged as a cornerstone for both beginners and experienced investors seeking passive income through Bitcoin(BTC) and Dogecoin( …
Bicara Therapeutics Announces Publication of an Abstract with Updated Interim Data from Phase 1/1b Trial of Ficerafusp alfa in 1L R/M HNSCC at the 2025 ASCO Annual Meeting
GlobeNewswire
·
May 22, 2025
BOSTON, May 22, 2025 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced the publication of an …
Maryna Karpenko Wins Top Industry Honors for Shaping Global Communication
GlobeNewswire
·
May 22, 2025
Image courtesy of Maryna Karpenko SAN FRANCISCO, May 22, 2025 (GLOBE NEWSWIRE) -- Maryna Karpenko, a product designer at Meta, helps shape the future of global communication, earning her top industry recognition, including the MUSE Creative Award, Vega …
Onconetix, Inc. Announces Receipt of Additional Notice from Nasdaq
GlobeNewswire
·
May 22, 2025
Cincinnati, OH, May 22, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (the “Company”) announced that it received a Staff delisting letter from The Nasdaq Capital Market (“Nasdaq”) on May 20, 2025 indicating that the Company’s failure to file its …
Serina Therapeutics Appoints Stephen Brannan, M.D. to Board of Directors
GlobeNewswire
·
May 22, 2025
- Renowned neuroscience drug developer joins to support strategic development of long-acting CNS therapeutics – HUNTSVILLE, AL, May 22, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology …
ESET participates in operation to disrupt the infrastructure of Danabot infostealer
GlobeNewswire
·
May 22, 2025
ESET Research has been tracking Danabot's activity since 2018 as part of a global effort that resulted in a major disruption of the malware's infrastructure. While primarily developed as an infostealer, Danabot also has been used to distribute additional …
Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Notice of General Meeting
GlobeNewswire
·
May 22, 2025
May 22, 2025 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Notice of General Meeting Biodexa Pharmaceuticals PLC, (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of …
Bio-Path Holdings to Host Corporate Update Conference Call on May 29, 2025
GlobeNewswire
·
May 22, 2025
HOUSTON, May 22, 2025 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (OTCQB:BPTH) a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer and obesity drugs, …
KMBIO announces Private sale for its P2P Exchange that connects Crypto World with Real Life
GlobeNewswire
·
May 22, 2025
GUADALAJARA, Mexico, May 22, 2025 (GLOBE NEWSWIRE) -- The countdown has begun, KMBIO an P2P exchange focusing on LATAM market has officially opened its private sale round as part of its fundraising campaign. In the midst of the global expansion of digital …
GENFIT Reports First Quarter 2025 Financial Information
GlobeNewswire
·
May 22, 2025
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), May 22, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver …
GENFIT : Information financière du premier trimestre 2025
GlobeNewswire
·
May 22, 2025
Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 22 mai 2025 – GENFIT (Nasdaq et Euronext : GNFT), société biopharmaceutique de stade clinique avancé engagée dans l’amélioration de la vie des patients atteints de maladies rares du …
Dianthus Therapeutics Appoints Simon Read, Ph.D., to Board of Directors
GlobeNewswire
·
May 22, 2025
Dr. Read brings >30 years of leadership and scientific expertise in the biopharmaceutical industry Previously served as CEO and Founder of Mariana Oncology until its acquisition by Novartis in 2024 and CSO of Ra Pharma until its acquisition by UCB in 2020 …
Senti Bio to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar
GlobeNewswire
·
May 22, 2025
SOUTH SAN FRANCISCO, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio” or the “Company”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene …
Rapid7 to Participate in Upcoming Investor Conferences
GlobeNewswire
·
May 22, 2025
BOSTON, May 22, 2025 (GLOBE NEWSWIRE) -- Rapid7, Inc. (NASDAQ: RPD), a leader in extended risk and threat detection, today announced that the company will be attending the following conferences: The William Blair 45th Annual Growth Stock Conference in …